Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 843

Results For "Pan"

9150 News Found

Shalby Hospitals teams up with Ganpat university to offer MBA in healthcare management
Hospitals | September 29, 2021

Shalby Hospitals teams up with Ganpat university to offer MBA in healthcare management

The aspirant can enrol in MBA (Healthcare and Hospital Management) at Ganpat University, -Centre for Management Studies and Research, which will be facilitated by Ganpat University and Shalby Centre for Healthcare Management and Research


MSD India launches 9-valent Human Papillomavirus (HPV) vaccine, GARDASIL 9
Drug Approval | September 29, 2021

MSD India launches 9-valent Human Papillomavirus (HPV) vaccine, GARDASIL 9

India’s first gender-neutral HPV vaccine to help reduce HPV -related disease burden in Indian girls, women and boys


Digital health-start-up MFine raises US $ 48 million
Startup | September 29, 2021

Digital health-start-up MFine raises US $ 48 million

Since its inception, over three million users have used MFine services with the platform clocking over three lakh monthly transactions


Bal Pharma ramps up API capacity of Gliclazide
News | September 28, 2021

Bal Pharma ramps up API capacity of Gliclazide

In terms of volume, the company commands a market share 25 per cent globally for Gliclazide, as per the IQVIA report


B2B pharma start-up MEDdelivery raises US $ 1 million
Startup | September 28, 2021

B2B pharma start-up MEDdelivery raises US $ 1 million

The company operates in over eight cities and the start-up plans to expand its reach to over 100 non-metro cities in the next 18-24 months


Zebra Medical Vision receives clearance for Coronary Artery Calcium (CAC) solution
Digitisation | September 28, 2021

Zebra Medical Vision receives clearance for Coronary Artery Calcium (CAC) solution

The CAC solution cleared by the U.S. FDA analyses already existing non-gated CT scans and quantifies the coronary artery calcium in order to identify, stratify, and facilitate treatment pathways for patients with cardiovascular disease


Eisai initiates rolling submission for Biological Licence Application of Lecanemab
Biotech | September 28, 2021

Eisai initiates rolling submission for Biological Licence Application of Lecanemab

The BLA is being submitted under the accelerated approval pathway and is primarily based on clinical, biomarker and safety data from the Phase 2b clinical trial in people with early AD and confirmed amyloid pathology


Positive results from Lynparza with abiraterone delays Metastatic prostrate cancer
Drug Approval | September 28, 2021

Positive results from Lynparza with abiraterone delays Metastatic prostrate cancer

Prostate cancer is the second-most common cancer in men and despite an increase in the number of available treatments for men with mCRPC, five-year survival remains low


Cardiovascular devices market to grow at a CAGR of 3.9 % up to 2027
News | September 28, 2021

Cardiovascular devices market to grow at a CAGR of 3.9 % up to 2027

One of the key factors driving the market growth is the rise in the occurrence of chronic cardiovascular diseases such as heart failure and coronary artery disease: Valuates Reports


Larsen & Toubro Infotech partners with eClinicalHealth to accelerate clinical research
Healthcare | September 28, 2021

Larsen & Toubro Infotech partners with eClinicalHealth to accelerate clinical research

As part of this strategic partnership, LTI with its digital, technical and life sciences domain capabilities, will help accelerate joint go-to-market pursuits and faster deployment for Clinpal Adopters